Respiratory viruses detected in severe acute respiratory infections and deaths in South Africa: Pathogen or passenger?

O. Helferschee(National Institute for Communicable Diseases), Marietjie Venter(University of the Witwatersrand), Jocelyn Moyes(University of the Witwatersrand), Marthi Pretorius(National Health Laboratory Service), Sumayya Haffjee(Metropolitan Hospital Center), Sibongile Walaza(National Health Laboratory Service), Shabir A. Madhi(University of the Witwatersrand), Ebrahim Variava(Kalafong Hospital), Cheryl Cohen(University of the Witwatersrand), Meera Chhagan(Metropolitan Hospital Center), Halima Dawood(Centre for the AIDS Programme of Research in South Africa)
International Journal of Infectious Diseases
April 1, 2014
10.1016/j.ijid.2014.03.729
Cited by 0

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|The Lancet|2017|2.4k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
|Cell|2022|1k